# Eran Harary

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eran-harary/

## Facts

| Field | Value |
| --- | --- |
| Citations | 327 |
| Field | Schizophrenia research and treatment |
| h-index | 10 |
| i10-index | 10 |
| Last Known Institution | Teva Pharmaceuticals (Israel) |
| OpenAlex ID | https://openalex.org/A5053278061 |
| Works | 28 |

## Researcher papers

- [Trazodone for the Treatment of Sexual Dysfunction Induced by Serotonin Reuptake Inhibitors](https://scholariq.org/papers/trazodone-for-the-treatment-of-sexual-dysfunction-induced-by-serotonin-reuptake/)
- [Clinical Characterization and the Caregiver Burden of Dementia in China](https://scholariq.org/papers/clinical-characterization-and-the-caregiver-burden-of-dementia-in-china/)
- [Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome](https://scholariq.org/papers/efficacy-and-safety-of-fixed-dose-deutetrabenazine-in-children-and-adolescents/)
- [Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome](https://scholariq.org/papers/safety-and-efficacy-of-flexible-dose-deutetrabenazine-in-children-and/)
- [Accuracy of self-reported premorbid functioning in schizophrenia](https://scholariq.org/papers/accuracy-of-self-reported-premorbid-functioning-in-schizophrenia/)
- [Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria](https://scholariq.org/papers/efficacy-and-safety-of-tv-46000-a-long-acting-subcutaneous-injectable/)
- [The burden of caring for dementia patients: caregiver reports from a cross-sectional hospital-based study in China](https://scholariq.org/papers/the-burden-of-caring-for-dementia-patients-caregiver-reports-from-a-cross/)
- [Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone](https://scholariq.org/papers/population-pharmacokinetic-modeling-and-simulation-of-tv-46000-a-long-acting/)
- [Safety and Efficacy of Long‐Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open‐Label Extension Study](https://scholariq.org/papers/safety-and-efficacy-of-long-term-deutetrabenazine-use-in-children-and/)
- [A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial](https://scholariq.org/papers/a-long-term-safety-and-tolerability-study-of-tv-46000-for-subcutaneous-use-in/)

## Researcher topics

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)
- [Attention Deficit Hyperactivity Disorder](https://scholariq.org/topics/attention-deficit-hyperactivity-disorder/)
- [Treatment of Major Depression](https://scholariq.org/topics/treatment-of-major-depression/)

## Researcher university

- [Teva Pharmaceuticals (Israel)](https://scholariq.org/institutions/teva-pharmaceuticals-israel/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.